Moreover, in AD mouse models, pharmacological inhibition or shRNA-mediated knockdown of PDE4D has been reported to restore amyloid-β (Aβ) induced memory deficits [18–21]. The gene discussed is PDE4D; the disease is Alzheimer disease.